Wird geladen...
Immunotherapy in Gynecologic Cancers: Are We There Yet?
Immune-targeted therapies have demonstrated durable responses in many tumor types with limited treatment options and poor overall prognosis. This has led to enthusiasm for expanding such therapies to other tumor types including gynecologic malignancies. The use of immunotherapy in gynecologic malign...
Gespeichert in:
| Veröffentlicht in: | Curr Treat Options Oncol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5936621/ https://ncbi.nlm.nih.gov/pubmed/28840453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-017-0504-y |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|